Company: SXTPW
Filing Date: 2025-03-27
Form Type: S-1/A
Source: 0001013762-25-003353
Chunk: 120

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: S-1/A
Chunk 120
---
 selling stockholder may hold, including   
 any other warrants that such selling stockholder may hold, that are not applicable to this         
 prospectus. On February 24, 2025, the Company effectuated a 1-for-5 Reverse Stock Split of         
 its outstanding common stock. Accordingly, all share numbers presented in this table have          
 been adjusted to reflect the Reverse Stock Split.                                                  |

| (2) | Assumes                                                                     
 the sale of all shares of common stock offered pursuant to this prospectus. |

| (3) | The securities to be sold pursuant to this                                                           
 prospectus consist of up to 177,037 (subject to adjustments) shares of common stock issued           
 or issuable upon exercise of Common Warrants, all of which are directly held by Mitchell             
 P. Kopin (“Mr. Kopin”) and Daniel B. Asher (“Mr. Asher”), each of                                    
 whom are managers of Intracoastal Capital LLC (“Intracoastal”), have shared voting                   
 control and investment discretion over the securities reported herein that are held by Intracoastal. 
 As a result, each of Mr. Kopin and Mr. Asher may be deemed to have beneficial ownership (as          
 determined under Section 13(d) of the Exchange Act) of the securities reported herein that           
 are held by Intracoastal. The address of the Intracoastal is 245 Palm Trail, Delray Beach            
 FL, 33483.                                                                                           |

| (4) | The securities to be sold pursuant to this                                                      
 prospectus consist of up to 177,428 (subject to adjustments) shares of common stock issued      
 or issuable upon exercise of Common Warrants. Hudson Bay Capital Management LP, the investment  
 manager of Hudson Bay Master Fund Ltd., has voting and investment power over these securities.  
 Sander Gerber is the managing member of Hudson Bay Capital GP LLC, which is the general partner 
 of Hudson Bay Capital Management LP. Each of Hudson Bay Master Fund Ltd. and Sander Gerber      
 disclaims beneficial ownership over these securities. The address of Hudson Bay Master Fund     
 Ltd. is c/o Hudson Bay Capital Management LP, 290 Harbor Dr., 3rd Floor, Stamford, CT 60902.    |

| (5) | The                                                                                                 
 securities to be sold pursuant to this prospectus consist of up to 102,253 (subject to adjustments) 
 shares of common stock issued or issuable upon exercise of Common Warrants, all